Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the study page. This indicates a minor maintenance update to the page metadata rather than changes to study data.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.4 replaces v3.5.3 on the page, indicating a minor page version update. The update does not specify changes to study details or results.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry v3.5.3 was added to the study page history, replacing the previous revision v3.5.2. This indicates a minor update to the page record without changes to the study content.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.2 is now shown on the page; the previous label v3.5.0 has been removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.5.0 is listed as the current version, replacing v3.4.3.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.